BBOT · BridgeBio Oncology Therapeutics, Inc. · Held by Funds
Market Cap
$221.28M
Shares
80.17M
Volume · Oct 20
660.94K
Avg daily vol (3M)
482.87K
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of BBOT by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 4.90% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.73% | 588,510 |
| Index ETFs | 4.17% | 3,339,228 |
| Active ETFs | 0.12% | 93,339 |
| Active funds | 2.58% | 2,065,415 |
| Unclassified | 0.00% | 1,033 |
| All registered funds | 7.59% | 6,087,525 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding BBOT
45 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 1,422,900 | $10,842,498 | 0.00% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 813,301 | $6,197,354 | 0.06% | Long | 2026-06-30 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 673,766 | $6,043,681 | 0.10% | Long | 2026-05-29 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 539,581 | $4,111,607 | 0.00% | Long | 2026-06-30 | |
| iShares Biotechnology ETF | IBB | 306,024 | $2,331,903 | 0.03% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 250,892 | $2,250,501 | 0.01% | Long | 2026-05-31 | |
| Select Biotechnology Portfolio | FBIOX | 240,300 | $2,155,491 | 0.04% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | SCHA | 227,258 | $2,038,504 | 0.01% | Long | 2026-05-31 | |
| BlackRock Health Sciences Term Trust | BMEZ | 263,669 | $2,009,158 | 0.19% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 222,512 | $1,695,541 | 0.01% | Long | 2026-06-30 | |
| ROYCE MICRO-CAP TRUST, INC. | RMT | 210,854 | $1,606,707 | 0.18% | Long | 2026-06-30 | |
| Victory Small Cap Stock Fund | — | 134,743 | $1,090,071 | 0.11% | Long | 2026-07-31 | |
| Tema Oncology ETF | CANC | 93,339 | $837,251 | 0.48% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 90,376 | $810,673 | 0.00% | Long | 2026-05-31 | |
| Royce Micro-Cap Fund | — | 87,617 | $667,642 | 0.16% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 72,932 | $654,200 | 0.00% | Long | 2026-05-31 | |
| BlackRock Health Sciences Trust | BME | 60,030 | $457,429 | 0.08% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 49,459 | $443,647 | 0.00% | Long | 2026-05-31 | |
| ROYCE SMALL-CAP TRUST, INC. | RVT | 44,789 | $341,292 | 0.01% | Long | 2026-06-30 | |
| Virtus Biotech Clinical Trials Etf | BBC | 40,107 | $324,466 | 0.70% | Long | 2026-07-31 | |
| Health Sciences Portfolio | — | 40,663 | $309,852 | 0.08% | Long | 2026-06-30 | |
| Royce Small-Cap Fund | — | 38,053 | $289,964 | 0.01% | Long | 2026-06-30 | |
| Schwab Total Stock Market Index Fund | SWTSX | 32,000 | $258,880 | 0.00% | Long | 2026-07-31 | |
| Schwab U.S. Broad Market ETF | SCHB | 27,500 | $246,675 | 0.00% | Long | 2026-05-31 | |
| Direxion Daily S&P Biotech Bull 3X Shares | LABU | 27,634 | $223,559 | 0.05% | Long | 2026-07-31 | |
| Royce Capital Fund - Micro-Cap Portfolio | — | 28,976 | $220,797 | 0.16% | Long | 2026-06-30 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 28,792 | $219,395 | 0.00% | Long | 2026-06-30 | |
| Fidelity ZERO Total Market Index Fund | FZROX | 24,941 | $201,773 | 0.00% | Long | 2026-07-31 | |
| ACUITAS US MICROCAP FUND | AFMCX | 24,350 | $185,547 | 0.16% | Long | 2026-06-30 | |
| Fidelity ZERO Extended Market Index Fund | FZIPX | 18,529 | $149,900 | 0.01% | Long | 2026-07-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 15,774 | $120,198 | 0.02% | Long | 2026-06-30 | |
| Small Cap Core Fund | — | 15,579 | $118,712 | 0.03% | Long | 2026-06-30 | |
| Harbor Active Small Cap Growth ETF | SGRW | 12,274 | $99,297 | 0.37% | Long | 2026-07-31 | |
| BIOTECHNOLOGY ULTRASECTOR PROFUND | — | 7,754 | $62,730 | 0.05% | Long | 2026-07-31 | |
| Fidelity Flex Small Cap Index Fund | FLXSX | 7,506 | $60,724 | 0.01% | Long | 2026-07-31 | |
| Health Sciences Trust | — | 7,262 | $55,336 | 0.02% | Long | 2026-06-30 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 4,884 | $37,216 | 0.02% | Long | 2026-06-30 | |
| VANGUARD BALANCED INDEX FUND | — | 4,825 | $36,767 | 0.00% | Long | 2026-06-30 | |
| VIP Extended Market Index Portfolio | — | 4,161 | $31,707 | 0.01% | Long | 2026-06-30 | |
| PROFUND VP BIOTECHNOLOGY | — | 3,606 | $27,478 | 0.06% | Long | 2026-06-30 | |
| Goldman Sachs Absolute Return Tracker Fund | — | 3,155 | $24,041 | 0.00% | Long | 2026-06-30 | |
| Total Stock Market Index Trust | — | 1,414 | $10,775 | 0.00% | Long | 2026-06-30 | |
| VIP Total Market Index Portfolio | — | 1,180 | $8,992 | 0.00% | Long | 2026-06-30 | |
| Pacer WealthShield ETF | PWS | 378 | $3,058 | 0.01% | Long | 2026-07-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 200 | $1,524 | 0.00% | Short | 2026-06-30 |
Showing 1–45 of 45 positions